Cantargia AB (publ) (7V3.F)

0.3902 +0.0102 (+2.68%) As of 09:16AM CEST. Market open.

Cantargia AB (publ)

Ideon Gateway
Scheelevägen 27
Lund 223 63
Sweden
46 4 62 75 62 60
https://cantargia.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 23

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Goran Forsberg	Chief Executive Officer	4.39M	N/A	1963
Mr. Thoas Fioretos M.D., Ph.D.	Founder & Scientific Advisor	355k	N/A	1962
Mr. Marcus Järås	Founder & Scientific Advisor	N/A	N/A	N/A
Mr. Kjell Sjöström	Founder	N/A	N/A	N/A
Mr. Patrik Renblad	Chief Financial Officer	N/A	N/A	1970
Ms. Liselotte Larsson	Chief Operating Officer	N/A	N/A	1963
Dr. David Liberg	Chief Scientific Officer	N/A	N/A	1969
Nina Valkama	Executive Assistant of Administration & Finance	N/A	N/A	N/A
Dr. Dominique Tersago	Chief Medical Officer	N/A	N/A	1962
Johanna Christensen	Financial Controller	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Cantargia AB (publ), a biotechnology company, develops antibody-based treatments for life threatening diseases. The company is developing CAN04 (nadunolimab), an interleukin-1 receptor accessory protein (IL1RAP) binding antibody, which is in Phase II clinical trial for the treatment of pancreatic cancer, non-small cell lung cancer, and triple-negative breast cancer; and CAN10, an antibody against IL1RAP, which is in preclinical phase for the treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis. It also develops CANxx, an IL1RAP-based antibody platform. The company has collaboration agreements with Patheon Biologics B.V. and BioWa Inc. for the manufacture and production of CAN04; and GEICAM, Spanish breast cancer group. Cantargia AB (publ) was incorporated in 2009 and is based in Lund, Sweden.

Corporate Governance

Cantargia AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.